TPG Group Holdings (SBS) Advisors, Inc.
Institutional investor · Portfolio as of Q3 2021
SEC EDGAR SourceSEC Filings
TPG Group Holdings (SBS) Advisors, Inc. manages $10.1B across 51 positions as of Q3 2021. Top holdings: LFST (25.2%), MCFE (13.2%), CWK (7.0%). Fund DNA: Balanced Allocator.
Top holdings by portfolio weight
LFST25.25%
MCFE13.22%
CWK6.98%
PGNY5.56%
ALLO4.78%
CNVY4.56%
ELV3.95%
FIS3.53%
TRI3.06%
FWONA2.64%
Other2.35%
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Upgrade to Pro to see the worst-performing positions.
View plansCost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Top Holdings51 positions
Activity:
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction | |
|---|---|---|---|---|---|---|---|---|
LIFESTANCE HEALTH GROUP INC | 175.3M | $2.5B | 25.2% | $28.80 | -73.44% | 2 qtrssince 2021-Q2 | Unchanged 0 | |
MCAFEE CORP | 60.2M | $1.3B | 13.2% | — | — | 4 qtrssince 2020-Q4 | Decreased 0 | |
CUSHMAN WAKEFIELD PLC | 37.8M | $702.6M | 7.0% | $18.70 | -33.42% | 9 qtrssince 2019-Q3 | Decreased 0 | |
PROGYNY INC | 10M | $560M | 5.6% | $28.20 | -17.55% | 8 qtrssince 2019-Q4 | Unchanged 0 | |
ALLOGENE THERAPEUTICS INC | 18.7M | $481M | 4.8% | $25.90 | -92.28% | 12 qtrssince 2018-Q4 | Unchanged 0 | |
CONVEY HEALTH SOLUTIONS HLDG | 54.7M | $459.5M | 4.6% | — | — | 2 qtrssince 2021-Q2 | Unchanged 0 | |
ELEVANCE HEALTH INC FORMERLY | 1.1M | $398.1M | 4.0% | $261.17 | +50.35% | 10 qtrssince 2019-Q2 | Increased 57 | |
FIDELITY NATL INFORMATION SV | 2.9M | $354.8M | 3.5% | $117.91 | -64.31% | 9 qtrssince 2019-Q3 | Increased 66 | |
THOMSON REUTERS CORP. | 2.8M | $308.4M | 3.1% | — | — | — | — | |
LIBERTY | 5.2M | $266M | 2.6% | — | — | — | — | |
Showing 10 of 51 results.41 more with Pro.PROUpgrade to see all → | ||||||||
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer